Cardiology & Vascular Diseases
Overview
Cardiology & Vascular Diseases focuses on diagnosing and treating conditions related to the heart and blood vessels. This includes managing heart diseases such as coronary artery disease and heart failure, as well as vascular conditions like aneurysms and peripheral artery disease. Specialists use various diagnostic tools and treatments to address issues affecting cardiovascular health and improve overall circulation and heart function.
Overview
Name
Cardiology & Vascular Diseases
Journals
439
Journals
| Journal | h-index | |
| 1. | Circulation | 674 |
| 2. | Journal of the American College of Cardiology | 493 |
| 3. | Circulation Research | 385 |
| 4. | Stroke | 357 |
| 5. | European Heart Journal | 348 |
| 6. | Cardiovascular Research | 244 |
| 7. | The American Journal of Cardiology | 237 |
| 8. | American Journal of Physiology. Heart and Circulatory Physiology | 224 |
| 9. | The Journal of Thoracic and Cardiovascular Surgery | 218 |
| 10. | Journal of Vascular Surgery | 218 |
Recent Articles
1.
Du B, Liang S, Zhang R, Shi W, Wang R, Qin Y, et al.
Echocardiography
. 2025 Mar;
42(3):e70091.
PMID: 40089901
Background: Right ventricular (RV) diastolic function and right atrial (RA) function are poorly characterized in patients with obstructive sleep apnea syndrome (OSAS), but may influence exercise capacity. We aimed to...
2.
Nanna M, Romero Acero L, Lee P
Echocardiography
. 2025 Mar;
42(3):e70129.
PMID: 40089896
No abstract available.
3.
Meng R, Li X, Liu H, Yi Z, Han Y, Xie Q, et al.
BMC Cardiovasc Disord
. 2025 Mar;
25(1):185.
PMID: 40089700
Background: Heart failure (HF) in elderly patients with concurrent hypotension presents a therapeutic challenge due to limited standard HF therapies' applicability. Recombinant human brain natriuretic peptide (rhBNP) and vasoactive medications...
4.
Liu Z, Han L, Mo L, Pang G, Xie Z, Huang Z
BMC Cardiovasc Disord
. 2025 Mar;
25(1):186.
PMID: 40089689
Background And Objectives: Venous-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) is a pivotal means for rapid cardiopulmonary support, yet it may result in lower limb ischemia. This study aims to explore the...
5.
Chua S, Chen J, Huang P, Chiu F, Wang Y, Hwang J, et al.
Cardiovasc Diabetol
. 2025 Mar;
24(1):122.
PMID: 40089685
No abstract available.
6.
Abazid R, Patil N, Elrayes M, Chandy M, Hassanin M, Mathew A, et al.
BMC Cardiovasc Disord
. 2025 Mar;
25(1):183.
PMID: 40089679
No abstract available.
7.
Liu Y, Xu L, Liu P, Liao X, Liao J
BMC Cardiovasc Disord
. 2025 Mar;
25(1):189.
PMID: 40089676
Background And Aims: The associations between screen time exposure, blood lipids, and Atherosclerotic Cardiovascular Disease (ASCVD) incidence have been less studied. We aimed to examine the associations of exposure to...
8.
Li J, Fu L, Zhang Y, Qiao T, Wang B
BMC Cardiovasc Disord
. 2025 Mar;
25(1):184.
PMID: 40089672
Background: Antithrombotic medications, including antiplatelet and anticoagulant therapies, are widely used to prevent thromboembolic events in patients with cardiovascular diseases. It is common for patients on antithrombotic medications to undergo...
9.
Xu J, Peng T, Kong L, Wei N
BMC Cardiovasc Disord
. 2025 Mar;
25(1):188.
PMID: 40089669
Aim: Ischemic heart disease (IHD) is a major contributor to global mortality and disability, imposing a significant health and economic burden on patients and society. Despite existing treatment options including...
10.
Odeberg J, Halling A, Ringborn M, Freitag M, Persson M, Vaara I, et al.
BMC Cardiovasc Disord
. 2025 Mar;
25(1):190.
PMID: 40089663
Background: Chronic low-grade inflammation is a well-known risk factor for coronary heart disease (CHD) and future cardiovascular events. Anti-inflammatory therapy can reduce the risk of ischemic cardiovascular disease (CVD) events...